GILD
Gilead Sciences, Inc.
- Research and development, 2025
- $5.8B
- YoY, 2025
- −1.8%
- 5-year CAGR
- +3.3%
- 10-year CAGR
- +6.8%
Research and development
Research and development by fiscal year
| Period | R&D | YoY |
|---|---|---|
| 2025 | $5.8B | −1.8% |
| 2024 | $5.9B | +3.3% |
| 2023 | $5.7B | +14.9% |
| 2022 | $5.0B | +8.2% |
| 2021 | $4.6B | −6.6% |
| 2020 | $4.9B | −45.9% |
| 2019 | $9.1B | +81.5% |
| 2018 | $5.0B | +34.4% |
| 2017 | $3.7B | −26.8% |
| 2016 | $5.1B | +69.1% |
| 2015 | $3.0B | +5.6% |
| 2014 | $2.9B | +34.6% |
| 2013 | $2.1B | +20.5% |
| 2012 | $1.8B | +43.2% |
| 2011 | $1.2B | +14.6% |
| 2010 | $1.1B | +14.2% |
| 2009 | $940M | +30.2% |
| 2008 | $722M | +22.1% |
| 2007 | $591M | — |